Screen LibraryNeurorehabilitation in neuro-oncology /
This book provides a comprehensive, practical, and timely guide to neurorehabilitation for patients affected by tumors of the central nervous system. These patients encounter various physical and psychosocial impairments, due to sensory-motor, psychological and cognitive limitations, as well as depr...
Saved in:
| Group Author: | ; ; |
|---|---|
| Published: |
Springer,
|
| Publisher Address: | Cham, Switzerland : |
| Publication Dates: | [2019] |
| Literature type: | Book |
| Language: | English |
| Subjects: | |
| Summary: |
This book provides a comprehensive, practical, and timely guide to neurorehabilitation for patients affected by tumors of the central nervous system. These patients encounter various physical and psychosocial impairments, due to sensory-motor, psychological and cognitive limitations, as well as depression, anxiety and fatigue. These common tumor and treatment consequences reduce quality of life and produce long-term limitation in functioning and disability that may benefit from rehabilitative interventions. In the early stages of the disease, rehabilitation aims at restoring functioning after tumor treatment, while in the advanced stages, rehabilitation becomes an integral part of palliative care, which aims to increase patients' independence, to prevent complications and to improve quality of life. Based on an interdisciplinary approach, the book is structured in two main parts. The first is devoted to the basics of cancer and to the main clinical features of the tumors of the nervous system, as well as to the essentials of therapeutic approaches. The second part is dedicated to rehabilitation issues, providing the tools for health personnel to take in charge persons affected by neuro-oncological disease. This unique volume is a valuable resource for all health professionals (physicians, psychologists, trainees nurses specialized in neuro-oncology, occupational therapists, physiotherapists, speech therapists) involved in the interdisciplinary management of individuals affected by tumors of the central nervous system. |
| Carrier Form: | x, 254 pages : illustrations (some color) ; 25 cm |
| Bibliography: | Includes bibliographical references. |
| ISBN: |
9783319956831 3319956833 |
| Index Number: | RC280 |
| CLC: | R739.410.9 |
| Call Number: | R739.410.9/N494 |
| Contents: |
Intro; Foreword; Preface; Contents; 1: Introduction; References; 2: Basics of Brain Tumor Biology for Clinicians; 2.1 Brain Tumor Risk; 2.2 Hallmarks of Brain Tumors; 2.2.1 Brain Tropism; 2.2.2 Angiogenesis; 2.2.3 Immunosuppression; 2.2.4 Metabolism; 2.2.5 Cancer Stem-Like Cells; 2.2.6 Clonal Evolution and Therapy Resistance; 2.3 Biological Features of Selected Brain Tumor Entities; 2.3.1 Diffusely Infiltrating Astrocytomas and Oligodendrogliomas; 2.3.2 Gliomas with Circumscribed Growth; 2.3.3 Medulloblastoma; 2.3.4 Meningiomas; 2.3.5 Brain Metastases; References 3: Classification of Tumours of the Central Nervous System3.1 Introduction; 3.2 Classification and Grading; 3.3 Glial Tumours; 3.3.1 Diffuse Gliomas; 3.3.1.1 Diffuse Astrocytoma, IDH-Mutant (Grade II) and Anaplastic Astrocytoma, IDH-Mutant (Grade III); 3.3.1.2 Diffuse Astrocytoma, IDH-Wildtype (Grade II) and Anaplastic Astrocytoma, IDH-Wildtype (Grade III); 3.3.1.3 Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted (Grade II) and Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q Codeleted (Grade III) 3.3.1.4 Glioblastoma, IDH-Wildtype (Grade IV) and Glioblastoma, IDH-Mutant (Grade IV)3.3.1.5 Diffuse Midline Glioma, H3 K27M-Mutant (Grade IV); 3.3.2 Other Astrocytic Gliomas; 3.3.3 Ependymomas; 3.4 Neuronal and Mixed Neuronal-Glial Tumours; 3.4.1 Dysembryoplastic Neuroepithelial Tumour (Grade I); 3.4.2 Ganglioglioma (Grade I) and Anaplastic Ganglioglioma (Grade III); 3.5 Embryonal Tumours; 3.5.1 Medulloblastoma (Grade IV); 3.5.2 Embryonal Tumour with Multi-Layered Rosettes, C19MC-Altered (Grade IV); 3.5.3 Atypical Teratoid/Rhabdoid Tumour (Grade IV); 3.6 Meningiomas 3.7 Familial Tumour Syndromes3.8 Metastatic Tumours; 3.9 Future Perspectives; References; 4: Clinical Concepts of Brain Tumors; 4.1 Generalized Symptoms; 4.1.1 Altered Mental Status and Behavior Changes; 4.1.2 Headache; 4.1.3 Nausea and Vomiting; 4.1.4 Papilledema; 4.2 Focal Symptoms; 4.2.1 Frontal Lobe Tumors; 4.2.2 Parietal Lobe Tumors; 4.2.3 Temporal Lobe Tumors; 4.2.4 Occipital Lobe Tumors; 4.2.5 Corpus Callosum; 4.2.6 Cerebellar Tumors; 4.2.7 Brainstem Tumors; 4.2.8 Sellar Tumors; 4.3 Clinical Aspects of CNS Tumors Depending on Histology 4.4 Brain Tumor-Related Epilepsy4.5 Clinical Complications of Treatments; 4.5.1 Side Effects of Steroids; 4.5.2 Infectious Complications; 4.5.3 Vascular Complications; 4.5.4 Hydrocephalus; 4.5.5 Endocrinological Complications; 4.5.6 Mood and Cognitive Complications; 4.6 Elderly Patients; References; 5: Imaging in Neuro-Oncology; 5.1 Introduction; 5.2 Radiogenomics; 5.3 Conventional Imaging; 5.4 Advanced Techniques; 5.4.1 Spectroscopy; 5.4.2 Diffusion Weighted Imaging and Diffusion Tensor Imaging; 5.4.3 Perfusion Imaging; 5.4.4 Functional MRI; References |